Log In
Print
BCIQ
Print
Print this Print this
 

R1578, RG1578

  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionMetabotropic glutamate receptor subtype 2 (mGluR2) antagonist
Molecular Target Metabotropic glutamate receptor subtype 2 (mGluR2) (GRM2)
Mechanism of ActionMetabotropic glutamate receptor subtype 2 (mGluR2) antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationDepression
Indication DetailsAdjunctive treatment of major depressive disorder (MDD); Treat depression
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today